| Literature DB >> 23698184 |
Samir Kumar Praharaj1, Amlan Kusum Jana, Sujit Sarkhel, Vinod Kumar Sinha.
Abstract
Ziprasidone is a second-generation antipsychotic with a lower propensity to cause extrapyramidal adverse effects that are seen at higher doses. We report a patient who developed acute dystonia, parkinsonism, and severe akathisia with ziprasidone 80 mg/d. These adverse effects subsided after dose reduction and specific treatment for akathisia and parkinsonism.Entities:
Mesh：
Substances：
Year: 2014 PMID： 23698184 DOI： 10.1097/MJT.0b013e318230ae52
Source DB: PubMed Journal: Am J Ther ISSN： 1075-2765 Impact factor: 2.688